New mechanisms of LDL-cholesterol induced endothelial dysfunction; correction by statins

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Atherosclerosis Research

Background:

• High LDL-cholesterol is a significant risk factor for atherosclerosis and cardiovascular events.
• Endothelial dysfunction, characterized by impaired nitric oxide (NO) production, is an early event in atherogenesis.
• The endothelial isoform of nitric oxide synthase (eNOS) plays a critical role in maintaining endothelial function.

Purpose of the Study:

• To elucidate the mechanism by which LDL-cholesterol causes endothelial toxicity.
• To investigate the role of caveolin-1 in mediating LDL-cholesterol-induced endothelial dysfunction.
• To evaluate the therapeutic potential of statins in restoring endothelial function.

Main Methods:

• Investigated the effect of LDL-cholesterol on endothelial cells in vitro.
• Examined the transcriptional regulation of caveolin-1 by intracellular cholesterol via Sterol Regulatory Element Binding Protein (SREBP).
• Assessed the impact of statin treatment on caveolin-1 expression and eNOS activity in vitro and in vivo using apoE-deficient mice.

Main Results:

• LDL-cholesterol alters eNOS activity without changing its expression, through transcriptional activation of caveolin-1.
• Increased intracellular cholesterol upregulates caveolin-1 gene transcription via SREBP.
• Statins prevented caveolin-1 upregulation and restored eNOS activity in both cell cultures and hypercholesterolemic mice.

Conclusions:

• LDL-cholesterol induces endothelial toxicity by upregulating caveolin-1, a negative regulator of eNOS.
• Cholesterol levels directly influence caveolin-1 transcription, impacting eNOS activity.
• Statins effectively reverse this detrimental pathway, highlighting their role in managing hypercholesterolemia-related endothelial dysfunction.